staurosporine has been researched along with palmitoylcarnitine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrand, H; Karabelas, K; Lundquist, B; Michelsen, P | 1 |
| Inui, N; Semba, M | 1 |
| Arese, P; Bussolino, F; Fischer, E; Kazatchkine, MD; Turrini, F | 1 |
| Biselli, R; De Simone, C; Farrace, S; Fattorossi, A | 1 |
| Imaizumi, Y; Muraki, K; Taki, H; Watanabe, M | 1 |
| Adachi, S; Babior, BM; Esser, V; Gottlieb, RA; Konyavko, M; McGarry, JD; Mutomba, MC; Yokoyama, CB; Yuan, H | 1 |
6 other study(ies) available for staurosporine and palmitoylcarnitine
| Article | Year |
|---|---|
Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Basophils; Calcimycin; Glyceryl Ethers; Histamine Release; Humans; Indoles; Isoquinolines; Maleimides; Mannitol; Palmitoylcarnitine; Piperazines; Polymyxin B; Protein Kinase C; Sphingosine; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate | 1992 |
Effects of activators and inhibitors of protein kinase C on two-stage transformation in BALB/3T3 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Cell Line; Cell Transformation, Neoplastic; Cocarcinogenesis; Diglycerides; Drug Antagonism; Enzyme Activation; Glycerides; Isoquinolines; Methylcholanthrene; Mice; Palmitoylcarnitine; Piperazines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate | 1990 |
Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1).
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Azo Compounds; Cell Adhesion; Complement System Proteins; Diamide; Enzyme Activation; Erythrocytes; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Monocytes; Palmitoylcarnitine; Phagocytosis; Phosphorylation; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Complement; Sphingosine; Staurosporine; Structure-Activity Relationship | 1989 |
Potentiation of human polymorphonuclear leukocyte activation by atrial natriuretic peptide. Inhibitory effect of carnitine congeners.
Topics: Atrial Natriuretic Factor; Carnitine; Cell Adhesion; Cell Membrane; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydrogen Peroxide; L-Selectin; Leukotriene B4; Macrophage-1 Antigen; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Palmitoylcarnitine; Protein Kinase C; Reactive Oxygen Species; Staurosporine | 1996 |
Mechanisms of the palmitoylcarnitine-induced response in vascular endothelial cells.
Topics: Acetylcholine; Animals; Aorta; Biological Transport; Calcium; Electric Conductivity; Endothelium, Vascular; Enzyme Inhibitors; GTP-Binding Proteins; Male; Muscle, Smooth; Palmitoylcarnitine; Pertussis Toxin; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rabbits; Staurosporine; Virulence Factors, Bordetella | 1999 |
Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine.
Topics: Acylation; Apoptosis; Carnitine; Carnitine O-Palmitoyltransferase; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; fas Receptor; Fibroblasts; Humans; Jurkat Cells; Palmitoyl Coenzyme A; Palmitoylcarnitine; Staurosporine | 2000 |